Moreover, knockdown of EZH2, as well as pharmacologic inhibition of EZH2, reduce the toxicity of chemotherapy agents in MM cells, confirming that EZH2 inactivation is the underlying mechanism of cell adhesion-mediated drug resistance62. This evidence concerns the gene EZH2 and Miyoshi myopathy.